The applicability of three different P(epsilon -caprolactone-co-DL-lactide)
copolymers for injection-molded controlled release devices was evaluated.
The copolymers of epsilon -caprolactone and DL-lactide were polymerized in
bulk using Sn(II) octoate as the catalyst. Glycerol, polyethylene glycol 10
00, and polyethylene glycol 4000 were used as initiators. Copolymers were c
haracterized by size exclusion chromatography, differential scanning calori
metry, and nuclear magnetic resonance spectroscopy measurements. The releas
e of two model compounds, theophylline and propranolol hydrochloride, at di
fferent loadings (2-30 wt %) was studied. The solubility of the model compo
unds into the matrices was confirmed to be low by DSC measurements. Increas
ing the hydrophilicity of the copolymer matrix increased the release rates
of both model compounds. The results clearly demonstrate that the desired r
elease rates of these model compounds can be tailored by varying the compou
nd loading or modifying the hydrophilicity of the matrix copolymer. The cop
olymers were found to be relatively stable during the 4-month hydrolysis. A
ddition of hydrophilic polyethylene glycol blocks into the backbone of the
copolymer chain increased water absorption and thus the degradation was fas
ter. (C) 2001 John Wiley & Sons, Inc.